Albany, New York, March 28, 2018: A new informative study titled “Thrombin Market – Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2017 – 2025” has recently been added to the repository of Market Research Reports Search Engine (MRRSE). According to the report, the global thrombin market is likely to grow at a CAGR of 3.8% during the assessment period. In terms of revenue, the market is likely to surpass US$ 690 Mn in revenues.
According to the report, growth of the global thrombin market is likely to grow on account of a range of factors, including increasing fatalities on account of hemorrhage or excessive bleeding. Increase in the number of surgical procedures carried out globally, especially the growth in developing countries, is also likely to provide an impetus to growth of the market. As thrombin is used in a number of surgical procedures, such as defibrination and clotting factor diagnostic tests, new opportunities are likely to emerge for manufacturers during the assessment period.
The report segments the global thrombin market into end user, dosage form, product and region. The end user segment is further sub-segmented into Academics and Research Institutes, Diagnostics Centers & Clinics and hospitals. The dosage form segment is categorized into solution forms, powder forms and others. By product, the report divided the global market into recombinant thrombin, human thrombin and bovine thrombin. Geographically, the market is divided into key regions globally which are North America, Europe, Asia Pacific and Rest of the world.
According to the report, bovine thrombin is likely to remain one of the leading segments on the basis of product type. Easy availability of bovine-based brands, combined with lesser complications are fuelling the demand for bovine thrombin during the assessment period. On the basis of end-user, hospitals are likely to remain the dominant segment globally. According to the report, the hospital segment accounted for over 50% revenue share of the market, and it is anticipated that this segment will continue to grow at a steady pace during the assessment period.
On the basis of region, North America and Asia Pacific are likely to be the leading markets for thrombin globally, followed by Europe. Demand for thrombin in North America is likely to be driven by strong adoption in the US. China and India are likely to remain the leading markets for thrombin in Asia Pacific, whereas demand is likely to remain concentrated in Western Europe.
The report profiles some of the leading players operating in the market. Some of these players are Johnson & Johnson Services, Inc., Mallinckrodt Pharmaceuticals, Pfizer, Inc., Shanghai RAAS blood products co., Ltd., Mochida Pharmaceutical Co., Ltd., Japan Blood Products Organization, BIOFAC A/S, Hualan Biological Engineering, Inc. and Biomed-Lublin S.A.
Browse Full Global Thrombin Market Report with TOC : https://www.mrrse.com/thrombin-market
Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.
MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.
90, State Street
Albany, NY – 12207